Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Marchetti

Showing results (181-190 of 450) with videos related to

Pageof 45
Sort By:
Oncotarget|November 22, 2017
PAX3d mRNA over 2.76 copies/µL in the bloodstream predicts cutaneous malignant melanoma relapseChiara Autilio, Carmela Paolillo, Maria Michela Lavieri, et al.
Biochemical Pharmacology|June 22, 2016
Hemiasterlin derivative (R)(S)(S)-BF65 and Akt inhibitor MK-2206 synergistically inhibit SKOV3 ovarian cancer cell growthWei-Ting Lai, Kai-Lin Cheng, Riccardo Baruchello, et al.
International Journal of Cardiology|February 19, 2013
Arterial thrombotic events and acute coronary syndromes with cancer drugs: are growth factors the missed link?: what both cardiologist and oncologist should know about novel angiogenesis inhibitorsElena Conti, Adriana Romiti, Maria Beatrice Musumeci, et al.
Anticancer Research|January 4, 2012
Somatostatin receptor subtype 2 A (SSTR2A) and HER2 expression in gastric adenocarcinomaAdriana Romiti, Roberta Di Rocco, Massimo Milione, et al.
World Journal of Oncology|October 7, 2017
FCGRs Polymorphisms and Response to Trastuzumab in Patients With HER2-Positive Breast Cancer: Far From Predictive Value?Andrea Botticelli, Federica Mazzuca, Marina Borro, et al.
Cancers|December 24, 2021
Impact of Sarcopenia and Inflammation on Patients with Advanced Non-Small Cell Lung Cancer (NCSCL) Treated with Immune Checkpoint Inhibitors (ICIs): A Prospective StudyMarta Tenuta, Alain Gelibter, Carla Pandozzi, et al.
Journal of Ultrasound|November 10, 2015
Positive impact of elastography in breast cancer diagnosis: an institutional experienceAndrea Botticelli, Eva Mazzotti, Domenica Di Stefano, et al.
Genes, Chromosomes & Cancer|August 31, 2002
High sensitivity of detection of TP53 somatic mutations by fluorescence-assisted mismatch analysisAlessandra Tessitore, Zorika Christiana Di Rocco, Katia Cannita, et al.
Breast (Edinburgh, Scotland)|February 8, 2022
Ribociclib plus letrozole in subgroups of special clinical interest with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: Subgroup analysis of the phase IIIb CompLEEment-1 trialPaul Cottu, Alistair Ring, Hikmat Abdel-Razeq, et al.
Plos One|March 28, 2013
Differential denaturation of serum proteome reveals a significant amount of hidden information in complex mixtures of proteinsVincenzo Verdoliva, Cinzia Senatore, Maria Letizia Polci, et al.
Pageof 45

Showing results (181-190 of 450) with videos related to

Sort By:
Pageof 45
Oncotarget|November 22, 2017
PAX3d mRNA over 2.76 copies/µL in the bloodstream predicts cutaneous malignant melanoma relapseChiara Autilio, Carmela Paolillo, Maria Michela Lavieri, et al.
Biochemical Pharmacology|June 22, 2016
Hemiasterlin derivative (R)(S)(S)-BF65 and Akt inhibitor MK-2206 synergistically inhibit SKOV3 ovarian cancer cell growthWei-Ting Lai, Kai-Lin Cheng, Riccardo Baruchello, et al.
International Journal of Cardiology|February 19, 2013
Arterial thrombotic events and acute coronary syndromes with cancer drugs: are growth factors the missed link?: what both cardiologist and oncologist should know about novel angiogenesis inhibitorsElena Conti, Adriana Romiti, Maria Beatrice Musumeci, et al.
Anticancer Research|January 4, 2012
Somatostatin receptor subtype 2 A (SSTR2A) and HER2 expression in gastric adenocarcinomaAdriana Romiti, Roberta Di Rocco, Massimo Milione, et al.
World Journal of Oncology|October 7, 2017
FCGRs Polymorphisms and Response to Trastuzumab in Patients With HER2-Positive Breast Cancer: Far From Predictive Value?Andrea Botticelli, Federica Mazzuca, Marina Borro, et al.
Cancers|December 24, 2021
Impact of Sarcopenia and Inflammation on Patients with Advanced Non-Small Cell Lung Cancer (NCSCL) Treated with Immune Checkpoint Inhibitors (ICIs): A Prospective StudyMarta Tenuta, Alain Gelibter, Carla Pandozzi, et al.
Journal of Ultrasound|November 10, 2015
Positive impact of elastography in breast cancer diagnosis: an institutional experienceAndrea Botticelli, Eva Mazzotti, Domenica Di Stefano, et al.
Genes, Chromosomes & Cancer|August 31, 2002
High sensitivity of detection of TP53 somatic mutations by fluorescence-assisted mismatch analysisAlessandra Tessitore, Zorika Christiana Di Rocco, Katia Cannita, et al.
Breast (Edinburgh, Scotland)|February 8, 2022
Ribociclib plus letrozole in subgroups of special clinical interest with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: Subgroup analysis of the phase IIIb CompLEEment-1 trialPaul Cottu, Alistair Ring, Hikmat Abdel-Razeq, et al.
Plos One|March 28, 2013
Differential denaturation of serum proteome reveals a significant amount of hidden information in complex mixtures of proteinsVincenzo Verdoliva, Cinzia Senatore, Maria Letizia Polci, et al.
Pageof 45